Search

Your search keyword '"Barracano R"' showing total 3 results
Start Over Author "Barracano R" Topic cardiac surgical procedures
3 results on '"Barracano R"'

1. Implantable cardiac electronic device therapy for patients with a systemic right ventricle.

Author

Barracano R, Brida M, Guarguagli S, Palmieri R, Diller GP, Gatzoulis MA, and Wong T

Subjects
Action Potentials, Arrhythmias, Cardiac etiology, Arrhythmias, Cardiac mortality, Arrhythmias, Cardiac physiopathology, Cardiac Surgical Procedures mortality, Death, Sudden, Cardiac etiology, Defibrillators, Implantable, Heart Defects, Congenital mortality, Heart Defects, Congenital physiopathology, Humans, Pacemaker, Artificial, Risk Assessment, Risk Factors, Treatment Outcome, Arrhythmias, Cardiac therapy, Cardiac Pacing, Artificial adverse effects, Cardiac Pacing, Artificial mortality, Cardiac Surgical Procedures adverse effects, Death, Sudden, Cardiac prevention & control, Electric Countershock adverse effects, Electric Countershock instrumentation, Electric Countershock mortality, Heart Conduction System physiopathology, Heart Defects, Congenital surgery, Heart Rate, Ventricular Function, Right
Abstract

The systemic right ventricle (SRV), defined as the morphological right ventricle supporting the systemic circulation, is relatively common in congenital heart disease (CHD). Our review aimed at examining the current evidence, knowledge gaps and technical considerations regarding implantable cardiac electronic device therapy in patients with SRV. The risk of sinus node dysfunction (SND) after atrial switch repair and/or complete heart block in congenitally corrected transposition of great arteries requiring permanent pacing increases with age. Similar to acquired heart disease, indication for pacing includes symptomatic bradycardia, SND and high degree atrioventricular nodal block. Right ventricular dysfunction and heart failure also represent important complications in SRV patients. Cardiac resynchronisation therapy (CRT) has been proposed to improve systolic function in SRV patients, although indications for CRT are not well defined and its potential benefit remains uncertain. Amongst adult CHD, patients with SRV are at the highest risk for sudden cardiac death (SCD). Nevertheless, risk stratification for SCD is scarce in this cohort and implantable cardioverter-defibrillator indication is currently limited to secondary prevention. Vascular access and the incidence of device-related complications, such as infections, inappropriate shocks and device system failure, represent additional challenges to implantable cardiac electronic device therapy in patients with SRV. A multidisciplinary approach with tertiary expertise and future collaborative research are all paramount to further the care for this challenging nonetheless ever increasing cohort of patients., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2020
Full Text
View/download PDF

2. A Very Late Life-Threatening Complication After Percutaneous Closure of an Atrial Septal Defect.

Author

Scognamiglio G, Barracano R, Colonna D, Mattera Iacono A, Santoro G, Spadafora A, Nappi G, Russo MG, and Sarubbi B

Subjects
Aortic Aneurysm, Thoracic diagnosis, Aortic Aneurysm, Thoracic surgery, Blood Vessel Prosthesis Implantation methods, Cardiac Catheterization adverse effects, Echocardiography, Transesophageal, Follow-Up Studies, Heart Septal Defects, Atrial diagnosis, Humans, Imaging, Three-Dimensional, Male, Time Factors, Tomography, X-Ray Computed, Young Adult, Aortic Aneurysm, Thoracic etiology, Cardiac Surgical Procedures adverse effects, Heart Septal Defects, Atrial surgery, Postoperative Complications, Septal Occluder Device adverse effects
Abstract

Percutaneous closure is widely recognized as the first therapeutic option in the majority of cases of secundum atrial septal defect (ASD) because of its high effectiveness and safety. Nonetheless, with the progressive increase of implanted devices and follow-up duration, several adverse events, some of them potentially life-threatening, have been reported. We report the case of an asymptomatic aortic erosion that occurred 13 years after the procedure. The main feature of our case is the very late occurrence of a life-threatening asymptomatic complication of ASD percutaneous closure, which should prompt lifelong surveillance in this population., (Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)

Published
2017
Full Text
View/download PDF

3. A Very Late Life-Threatening Complication After Percutaneous Closure of an Atrial Septal Defect

Author

Maria Giovanna Russo, Gianantonio Nappi, Berardo Sarubbi, Giancarlo Scognamiglio, Andrea Spadafora, Diego Colonna, Giuseppe Santoro, Rosaria Barracano, Agostino Mattera Iacono, Scognamiglio, G., Barracano, R., Colonna, D., Mattera Iacono, A., Santoro, G., Spadafora, A., Nappi, G., Russo, M. G., and Sarubbi, B.

Subjects
Male, Cardiac Catheterization, medicine.medical_specialty, Time Factors, Percutaneous, Time Factor, Septal Occluder Device, Population, Septum secundum, 030204 cardiovascular system & hematology, Asymptomatic, Heart Septal Defects, Atrial, Follow-Up Studie, Blood Vessel Prosthesis Implantation, Young Adult, 03 medical and health sciences, Aortic aneurysm, Imaging, Three-Dimensional, Postoperative Complications, 0302 clinical medicine, Internal medicine, Humans, Cardiac Surgical Procedure, Medicine, 030212 general & internal medicine, Cardiac Surgical Procedures, education, Heart septal defect, education.field_of_study, Aortic Aneurysm, Thoracic, business.industry, medicine.disease, Surgery, Cardiothoracic surgery, Cardiology, medicine.symptom, Tomography, X-Ray Computed, Cardiology and Cardiovascular Medicine, business, Complication, Echocardiography, Transesophageal, Follow-Up Studies, Human
Abstract

Percutaneous closure is widely recognized as the first therapeutic option in the majority of cases of secundum atrial septal defect (ASD) because of its high effectiveness and safety. Nonetheless, with the progressive increase of implanted devices and follow-up duration, several adverse events, some of them potentially life-threatening, have been reported. We report the case of an asymptomatic aortic erosion that occurred 13 years after the procedure. The main feature of our case is the very late occurrence of a life-threatening asymptomatic complication of ASD percutaneous closure, which should prompt lifelong surveillance in this population.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results